DAVIDE DEBELLIS: Open Payments
NPI 1871512202 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 21 payments from 9 companies in 2025. Trend: 2023 $441 · 2024 $360 · 2025 $613
Food & beverage: $613
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $149 |
| AstraZeneca Pharmaceuticals LP | 2 | $139 |
| Lilly USA, LLC | 4 | $96 |
| Exact Sciences Corporation | 2 | $62 |
| COLOPLAST CORP | 1 | $58 |
| Inspire Medical Systems, Inc. | 1 | $36 |
| Novo Nordisk Inc | 2 | $35 |
| Insulet Corporation | 1 | $23 |
| Calliditas Therapeutics US Inc. | 1 | $15 |
Products named: AIRSUPRA, NUCALA, Titan, JARDIANCE, MOUNJARO, INSPIRE, Cologuard Collection Kit, The Cologuard Plus Collection Kit.
Industry payments across NY — which companies pay providers there.
